Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
12/2005
12/01/2005WO2005007124A3 Substituted dihydropyrimidine inhibitors of calcium channel function
12/01/2005US20050267171 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267126 Compounds derived from aryl carbamates, preparation thereof and uses of same
12/01/2005US20050267123 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
12/01/2005DE102004023506A1 Kettenverlängerte substituierte Cyclohexyl-1,4-diamin-Derivate Chain-substituted cyclohexyl-1,4-diamine derivatives
12/01/2005CA2566934A1 Tetrahydronaphthyl- piperazines as 5-ht1b antagonists, inverse agonists and partial agonists
12/01/2005CA2564365A1 Compounds and compositions as ppar modulators
11/2005
11/30/2005EP1600442A1 Heteroarylcarbamoylbenzene derivative
11/30/2005EP1599484A2 Process for the preparation of hexacyclic camptothecin derivatives
11/30/2005EP1599468A1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
11/30/2005EP1599465A1 Substituted n-aryl nitrogen heterocycles
11/30/2005EP0939844B1 Paper production process
11/30/2005CN1703412A Novel compounds with antibacterial activity
11/30/2005CN1703405A Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors
11/30/2005CN1703401A Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1701814A F1K-1 is a receptor for vascular endothelial growth factor
11/30/2005CN1229355C Substituted fluoroalcoxyphenylsulfonylurea
11/30/2005CN1229353C Method and compositions utilizing quinazolinones
11/30/2005CN1229329C Substituted amino amide salicylate with fungal killing function and its prepared intermediate thereof
11/29/2005US6969767 5-(haloalkyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine; enzymatic process for intermediate's synthesis and transformation to (+)-zopiclone
11/29/2005US6969715 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
11/29/2005US6969713 Piperidine and piperazine acetamide derivatives
11/29/2005US6969697 Substituted benzoylcyclohexenones
11/24/2005WO2005110975A1 Substituted cyclohexyl-1,4-diamine derivatives with a chain extension
11/24/2005WO2005110416A2 4,5-disubstituted-2-aryl pyrimidines
11/24/2005WO2005046604A3 Heteroaryl-hydrazone compounds
11/24/2005WO2004016598A8 Monomers capable of forming four hydrogen bridges and supramolecular polymers formed by copolymerization of these monomers with regular monomers
11/24/2005US20050261503 Heteroaromatic glucokinase activators
11/24/2005US20050261319 Novel 2-amino-4-quinazolinones and 2-amino-4-oxoquinazolones as LXR nuclear receptor binding compounds with partial agonistic properties
11/24/2005US20050261318 Protein kinase inhibitors
11/24/2005US20050261305 Cyclic protein tyrosine kinase inhibitors
11/24/2005US20050261303 e.g. (2R,5S)-4-(3-chloro-4-cyanophenyl)-N-(2-cyclopropylpyrimidin-5-yl)-2,5-dimethylpiperazine-1-carboxamide; antiandrogenic agent
11/24/2005US20050261295 Pyrimidine as PLK inhibitors
11/24/2005US20050261294 Substituted heteroaryl derivatives, compositions, and methods of use
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005US20050261271 Dipeptidyl peptidase inhibitors
11/24/2005US20050258400 Nematic or cholesteric or chiral-smectic; high absolute values of dielectric anisotropy combined with a favorable ratio of viscosity to clearing point; light- and UV-stable, and also thermally stable; high voltage holding ratio
11/24/2005DE102004022728A1 Fluorierte Phenanthrene und ihre Verwendung in Flüssigkristallmischungen Fluorinated phenanthrenes and their use in liquid crystal mixtures
11/24/2005CA2566917A1 Compounds containing a n-heteroaryl moiety linked to fused ring moieties for the inhibition of nad(p)h oxidases and platelet activation
11/24/2005CA2563607A1 4,5-disubstituted-2-aryl pyrimidines
11/23/2005EP1598343A1 2-Arylaminopyrimidine derivatives as PLK inhibitors
11/23/2005EP1597322A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
11/23/2005EP1597251A2 Pyrimidine compounds
11/23/2005EP1597240A1 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof
11/23/2005EP1597239A1 Polymorph of {6,7-bis(2-methoxy-ethoxy)-quinazolin-4-yl}-(3e)
11/23/2005EP1597238A1 Hiv replication inhibiting pyrimidines and triazines
11/23/2005EP1597237A1 Pyrimidine derivatives for the prevention of hiv infection
11/23/2005CN1699350A Processes and intermediates for preparing anti-cancer compounds
11/23/2005CN1699349A Method and reagents for N-alkylating ureides
11/23/2005CN1228327C Carboxylic acid derivatives and drugs containing the same
11/22/2005US6967251 Reagents for labeling biomolecules having aldehyde or ketone moieties
11/22/2005US6967079 Pyrimidine derivatives for labeled binding partners
11/22/2005CA2187174C .alpha.-substituted phenylacetic acid derivative, process for producing the same, and agricultural bactericide containing the same
11/22/2005CA2129528C Herbicidal n-[(pyrimidin-2-yl)aminocarbonyl]-benzenesulfonamides
11/17/2005WO2005108404A1 Heavy metal complex of ethynyl group-substituted fused heterocyclic compound, method for producing same, synthetic intermediate thereof, method for producing same, and organic electroluminescent device
11/17/2005WO2005108381A1 Synthesis and uses of synephrine derivatives
11/17/2005WO2005108377A1 Pharmaceutical compositions
11/17/2005WO2005108376A1 Calcilytic compounds
11/17/2005WO2005107758A1 4-phenylamino-quinazolin-6-yl-amides
11/17/2005WO2005051906A3 Heterocyclic inhibitors of mek and methods of use thereof
11/17/2005WO2005023204A3 Aromatic prodrugs of propofol, compositions and uses thereof
11/17/2005WO2005016264A3 Diamine derivatives of quinone and uses thereof
11/17/2005US20050255055 Protecting human and animal hair or skin from UV radiation by applying a 4,4-disubstituted -1,3-butadienylamine; 4,4-substituents may be the same or different and are cyano, ester, sec. or tert. amide, ketone and/or sulfone, e.g., 4,4-bis(hexyloxycarbonyl)-N,N-diethyl-1,3-butadienylamine
11/17/2005US20050253112 Luminescent compositions
11/17/2005DE102004020908A1 Substituierte 5,6,7,8,-Tetrahydro-pyrido[4,3-d]pyrimidin-2-yl- und 5,6,7,8,-Tetrahydro-chinazolin-2-yl-Verbindungen Substituted 5,6,7,8-tetrahydro-pyrido [4,3-d] pyrimidin-2-yl and 5,6,7,8-tetrahydro-quinazolin-2-yl compounds
11/16/2005EP1595870A1 Process for producing phenylalanine derivative having quinazolinedione skeleton and intermediate for the same
11/16/2005EP1594863A1 Tri(cyclo) substituted amide glucokinase activator compounds
11/16/2005EP1594849A2 Compounds, compositions, and methods
11/16/2005EP1594848A1 Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds
11/16/2005EP1594846A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists
11/16/2005EP1594505A2 Phenylglycine derivatives useful as serine protease inhibitors
11/16/2005EP1594504A2 Novel irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and uses thereof for therapy and diagnosis
11/16/2005EP1421634B1 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
11/16/2005EP1257550B1 Platelet adp receptor inhibitors
11/16/2005EP0834074B2 Detection of transmembrane potentials by optical methods
11/16/2005CN1697830A 嘧啶衍生物 Pyrimidine derivatives
11/16/2005CN1697829A Synthesis of chlorinated pyrimidines
11/16/2005CN1227249C Pyrimidine compounds
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/16/2005CN1227234C Substituted iminoazines
11/15/2005US6964973 Nonsteroidal agonists and antagonists
11/15/2005US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use
11/15/2005US6964701 Azo dyes containing a barbituric acid moiety, ink-jet printing inks and processes
11/15/2005CA2172534C Conformationally locked nucleoside analogues
11/10/2005WO2005105950A1 Electroluminescent device
11/10/2005WO2005105764A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005WO2005105761A1 Morpholinylanilinoquinazo- line derivatives for use as antiviral agents
11/10/2005WO2005105760A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
11/10/2005WO2005105759A1 Substituted 5, 6, 7, 8-tetrahydro-pyrido[4, 3-d]pyrimidine-2-yl compounds and 5, 6, 7, 8-tetrahydro-quinazoline-2-yl compounds
11/10/2005WO2005105758A1 Tri-substituted ureas as cytokine inhibitors
11/10/2005WO2005105757A1 Tri-substituted ureas as cytokine inhibitors
11/10/2005WO2005105744A1 Histamine-3 receptor antagonists
11/10/2005US20050250944 Synthesis and uses of synephrine derivatives
11/10/2005US20050250822 Substituted benzanilide compound and noxious organism controlling agent
11/10/2005US20050250810 Screening for an enzyme inhibitor of Fab I or Fab K using providing a reaction mixture comprising Fab I or Fab K, crotonyl-ACP and NAPDH or NADH; contacting a candidate compound with the reaction mixture; and detecting inhibition of Fab I or Fab K; bactericides; fungicides; antibiotics; Stapylococcus
11/10/2005US20050250787 Pyrimidine compounds
11/10/2005US20050250782 Heterocyclic inhibitors of MEK and methods of use thereof
1 ... 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 ... 427